Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
Guangdong Provincial People's Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)